2025-12-03 REL PDBe INITIAL_RELEASE REPOSITORY PDBe PDBe 2025-10-24 2025-12-03 2025-12-03 2025-12-03 European Research Council (ERC) ERC-2012-StG-311460 DrugE3CRLs European Union European Research Council (ERC) 875510 European Union Medical Research Council (MRC, United Kingdom) MR/R015791/1 United Kingdom Wellcome Trust 223816/Z/21/Z United Kingdom Medical Research Council (MRC, United Kingdom) PO 4050845509 United Kingdom The Cullin 2 RING VHL E3 ligase dimerised by the homoPROTAC CM11 Crowe C Ciulli A PROTAC, homoPROTAC, dimerizer, CM11, VHL, von Hippel-Lindau, Cullin 2, RING, E3, ligase, targeted protein degradation Crowe C Salerno A Sathe G Marsh G Maple H Ciulli A Linker-rigidified VHL homodimerizers convert degraders into stabilizers of non-ubiquitinable ternary complexes Biorxiv US 2025 doi:10.1101/2025.11.18.689129 2692-8205 9t32 FULLOVERLAP EMDB EMD-55480 associated EM volume
The Cullin 2 RING VHL E3 ligase dimerised by the homoPROTAC CM11
 The ternary complex of the heteropentameric CRL2VHL (VHL-ElonginC-ElonginC-Cul2-Rbx1) dimerized by the homoPROTAC CM11 The ternary complex of the heteropentameric CRL2VHL (VHL-ElonginC-ElonginC-Cul2-Rbx1) dimerized by the homoPROTAC CM11 0 1 2 3 4 5 Homo sapiens Elongin-B Homo sapiens 0.011619226 2 Escherichia coli LEVO MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFR ADDTFEALCIEPFSSPPELPDVM Q15370 Elongin-C Homo sapiens 0.010740277 2 Escherichia coli LEVO MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIA PEIALELLMAANFLD Q15369 Cullin-2 Homo sapiens 0.076636797 2 Escherichia coli LEVO KPRVVDFDETWNKLLTTIKAVVMLEYVERATWNDRFSDIYALCVAYPEPLGERLYTETKIFLENHVRHLHKRVLESEEQV LVMYHRYWEEYSKGADYMDCLYRYLNTQFIKKNKLTEADLQYGYGGVDMNEPLMEIGELALDMWRKLMVEPLQAILIRML LREIKNDRGGEDPNQKVIHGVINSFVHVEQYKKKFPLKFYQEIFESPFLTETGEYYKQEASNLLQESNCSQYMEKVLGRL KDEEIRCRKYLHPSSYTKVIHECQQRMVADHLQFLHAECHNIIRQEKKNDMANMYVLLRAVSTGLPHMIQELQNHIHDEG LRATSNLTQENMPTLFVESVLEVHGKFVQLINTVLNGDQHFMSALDKALTSVVNYREPKSVCKAPELLAKYCDNLLKKSA KGMTENEVEDRLTSFITVFKYIDDKDVFQKFYARMLAKRLIHGLSMSMDSEEAMINKLKQACGYEFTSKLHRMYTDMSVS ADLNNKFNNFIKNQDTVIDLGISFQIYVLQAGAWPLTQAPSSTFAIPQELEKSVQMFELFYSQHFSGRKLTWLHYLCTGE VKMNYLGKPYVAMVTTYQMAVLLAFNNSETVSYKELQDSTQMNEKELTKTIKSLLDVKMINHDSEKEDIDAESSFSLNMN FSSKRTKFKITTSMQ Q13617 E3 ubiquitin-protein ligase RBX1, N-terminally processed Homo sapiens 0.010526048 2 Escherichia coli LEVO KRFEVKKWNAVALWAWDIVVDNCAICRNHIMDLCIECQANQASATSEECTVAWGVCNHAFHFHCISRWLKTRQVCPLDNR EWEFQKYGH P62877 von Hippel-Lindau disease tumor suppressor Homo sapiens 0.01633562 2 Escherichia coli LEVO VLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLN VDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLT P40337 (2~{S},4~{R})-1-[(2~{S})-2-[2-[2-[2-[2-[2-[2-[2-[[(2~{S})-3,3-dimethyl-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]-4-oxidanyl-pyrrolidin-1-yl]-1-oxidanylidene-butan-2-yl]amino]-2-oxidanylidene-ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanoylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide 0.001179447 1 A1JTC singleParticle threeDArray 7.5 ETHANE FEI VITROBOT MARK IV TFS GLACIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 200 1.7 3.2 FEI FALCON IV (4k x 4k) 57.0 1 PHASE FLIPPING AND AMPLITUDE CORRECTION 8RWZ 6.9 FSC 0.143 CUT-OFF cryoSPARC 68789 MAXIMUM LIKELIHOOD MAXIMUM LIKELIHOOD emd_55480.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 600 600 600 0 0 0 600 600 600 444.0 444.0 444.0 90.0 90.0 90.0 X Y Z -0.039400566 0.115613624 0.00050421513 0.0031562021 0.74 0.74 0.74 0.0183 AUTHOR emd_55480_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 600 600 600 0 0 0 600 600 600 444.0 444.0 444.0 90.0 90.0 90.0 X Y Z -0.12857203 0.15067044 0.00028326368 0.01410266 0.74 0.74 0.74 AUTHOR emd_55480_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 600 600 600 0 0 0 600 600 600 444.0 444.0 444.0 90.0 90.0 90.0 X Y Z -0.14416672 0.1469575 0.00028180808 0.014376968 0.74 0.74 0.74 AUTHOR